Showing results (421-430 of 479) with videos related to
Sort By:
Pageof 48
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongueCherry L Estilo, Pornchai O-Charoenrat, Ivan Ngai, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancerMatthew G Fury, Eric Sherman, Donna Lisa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II StudyJoshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.Cancer Chemotherapy and Pharmacology|June 15, 2000
Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathwayL Chie, S Amar, H F Kung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancerChristopher G Azzoli, Sherman Baker, Sarah Temin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical OncologyA Recht, S B Edge, L J Solin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung CancerChristopher G Azzoli, Sarah Temin, Timothy Aliff, et al.JAMA Network Open|June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled TrialNancy Y Lee, Jonathan Harris, John Kim, et al.The New England Journal of Medicine|February 15, 2013
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancerAlan L Ho, Ravinder K Grewal, Rebecca Leboeuf, et al.International Journal of Cancer|February 26, 2013
Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancerAnuj Goenka, Luc G T Morris, Shyam S Rao, et al.Pageof 48